Mismatch repair deficiency concordance between primary colorectal cancer and corresponding metastasis

Familial Cancer

Volumn 15, Issue 2, 2016, Pages 253-260

  Haraldsdottir, Sigurdis ^a   Roth, Rachel ^b   Pearlman, Rachel ^b   Hampel, Heather ^b   Arnold, Christina A ^b   Frankel, Wendy L ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Colorectal cancer; Concordance; Deficient mismatch repair system; Immunohistochemistry; Lynch syndrome; Metastatic cancer

Indexed keywords

MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; DNA BINDING PROTEIN; G-T MISMATCH-BINDING PROTEIN; MLH1 PROTEIN, HUMAN; MSH2 PROTEIN, HUMAN; MUTL PROTEIN HOMOLOG 1; PMS2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER SURGERY; COLORECTAL CANCER; COLORECTAL LIVER METASTASIS; COLORECTAL SURGERY; DISTANT METASTASIS; DNA METHYLATION; FEMALE; GENE MUTATION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTASIS RESECTION; MISMATCH REPAIR; MISMATCH REPAIR DEFICIENCY; MUSCLE METASTASIS; MUTATIONAL ANALYSIS; OMENTUM METASTASIS; PERITONEUM METASTASIS; PRIMARY TUMOR; PRIORITY JOURNAL; PROMOTER REGION; REGIONAL METASTASIS; RETROPERITONEAL CANCER; SOFT TISSUE METASTASIS; SOMATIC MUTATION; COLORECTAL TUMOR; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MISMATCH REPAIR ENDONUCLEASE PMS2; MUTL PROTEIN HOMOLOG 1; MUTS HOMOLOG 2 PROTEIN; YOUNG ADULT;

EID: 84949792881     PISSN: 13899600     EISSN: 15737292     Source Type: Journal    
DOI: 10.1007/s10689-015-9856-2     Document Type: Article

References (27)

1. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M (1993) Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363:558–561
2. Risinger JI, Berchuck A, Kohler MF, Watson P, Lynch HT, Boyd J (1993) Genetic instability of microsatellites in endometrial carcinoma. Cancer Res 53(21):5100–5103
3. Hampel H, Frankel WL, Martin E et al (2005) Screening for the Lynch Syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352(18):1851–1860
4. Kane MF, Loda M, Gaida GM et al (1997) Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57:808–811
5. Haraldsdottir S, Hampel H, Tomsic J et al (2014) Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations. Gastroenterology 147(6):1308–1316
6. Mensenkamp AR, Vogelaar IP, van Zelst-Stams WAG et al (2014) Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors. Gastroenterology 146(3):643–646
7. Rodríguez-Soler M, Pérez-Carbonell L, Guarinos C et al (2013) Risk of cancer in cases of suspected lynch syndrome without germline mutation. Gastroenterology 144(5):926–932
8. Palomaki GE, McClain MR, Melillo S, Hampel HL, Thibodeau SN (2009) EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genet Med 11(1):42–65
9. Network NCC (2014) NCCN genetic/familial high-risk assessment: colorectal. Version 1.2014. Accessed 30 April 2014
10. Giardiello FM, Allen JI, Axilbund JE et al (2014) Guidelines on genetic evaluation and management of lynch syndrome: a consensus statement by the US multi-society task force on colorectal cancer. Gastroenterology 147(2):502–526
11. Ribic CM, Sargent DJ, Moore MJ et al (2003) Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 349:247–257
12. Sargent DJ, Marsoni S, Monges G et al (2010) Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol 28(20):3219–3226
13. Network NCC (2015) NCCN clinical practice guidelines in oncology: thyroid carcinoma. Version 3.2015. Accessed 24 July 2015
14. Le DT, Uram JN, Wang H et al (2015) PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med 372(26):2509–2520
15. Leach FS, Polyak K, Burrell M et al (1996) Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues. Cancer Res 56(2):235–240
16. Aaltonen L, Peltomaki P, Leach F et al (1993) Clues to the pathogenesis of familial colorectal cancer. Science 260(5109):812–816
17. Salahshor S, Koelble K, Rubio C, Lindblom A (2001) Microsatellite Instability and hMLH1 and hMSH2 expression analysis in familial and sporadic colorectal cancer. Lab Investig J Tech Methods Pathol 81(4):535–541
18. Shia J (2008) Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: part I. The utility of immunohistochemistry. J Mol Diagn 10(4):293–300
19. Kumarasinghe AP, de Boer B, Bateman AC, Kumarasinghe MP (2010) DNA mismatch repair enzyme immunohistochemistry in colorectal cancer: a comparison of biopsy and resection material. Pathology 42(5):414–420
20. Shia J, Stadler Z, Weiser MR et al (2011) Immunohistochemical staining for DNA mismatch repair proteins in intestinal tract carcinoma: how reliable are biopsy samples? Am J Surg Pathol 35(3):447–454
21. Warrier SK, Trainer AH, Lynch AC et al (2011) Preoperative diagnosis of Lynch syndrome with DNA mismatch repair immunohistochemistry on a diagnostic biopsy. Dis Colon Rectum 54(12):1480–1487
22. Kononen J, Bubendorf L, Kallioniemi A et al (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4(7):844–847
23. Hendriks Y, Franken P, Dierssen JW et al (2003) Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors. Am J Pathol 162:469–477
24. ClinicalTrials.gov. Ohio Colorectal Cancer Prevention Initiative (OCCPI). http://clinicaltrials.gov/show/NCT01850654. Accessed 04 Oct 2014
25. Hampel H, Frankel WL, Martin E et al (2008) Feasibility of screening for lynch syndrome among patients with colorectal cancer. J Clin Oncol 26(35):5783–5788
26. Herman JG, Umar A, Polyak K et al (1998) Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 95(12):6870–6875
27. Larsen NB, HeibergEngel PJ, Rasmussen M, Rasmussen LJ (2009) Differential expression of hMLH1 in sporadic human colorectal cancer tumors and distant metastases. APMIS 117(11):839–848